Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.23.2
Subsequent Events (Details)
$ in Thousands
6 Months Ended
Jul. 28, 2023
USD ($)
Mar. 15, 2023
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Debt Instrument [Line Items]        
Reverse split ratio   0.0667    
Equity security issuance     $ 1,109 $ 4,212
Subsequent Event [Member] | uBriGene        
Debt Instrument [Line Items]        
Base consideration $ 6,000      
Contingent amount 5,000      
Equity security issuance $ 10,000